Related Information

Stay connected. Sign up now to be informed of the latest FasterCures blogs, events and program updates.

 

Partnering for Cures

On December 14-15, 2010, join FasterCures, the Washington, DC-based center of the Milken Institute, at the second Partnering for Cures meeting convened to advance the goal of bringing effective therapies to patients faster.

Partnering for Cures brings together all the sectors engaged in the research enterprise to facilitate strategic collaborations needed to turn scientific discoveries into accessible therapies.

Partnering for Cures 2010 Features:

  • ONE-ON-ONE PARTNERING MEETINGS. Connect with nontraditional allies to accelerate the collaboration process through pre-arranged private meetings.
  • THERAPEUTIC AFFINITY ROUNDTABLES. Engage with leaders in your field representing different sectors through focused, informal networking opportunities.
  • INNOVATOR PRESENTATIONS. Learn first-hand about new research strategies, multi-sector collaborations, and novel development portfolios from dozens medical innovators.
  • HOT-BUTTON PANELS. Participate in dynamic, candid, cutting-edge discussions about key topics in medical research including translational research, shelved compounds, data networks, and many more.
  • TECHNICAL EXPERT CONSULTATIONS (NEW IN 2010). Access technical and scientific experts on-site to help you address some of your organization's mission-critical challenges.

Register now and plan to join us at Partnering for Cures 2010.

In 2009, the inaugural Partnering for Cures meeting was a resounding success, with over 600 medical research executives, scientists, policy makers, and funders participating and more than 500 one-on-one meetings scheduled through the partnering database. Beyond the numbers, we measure the meeting's impact by the feedback we continue to receive about its outcomes - from the conception of innovative programs, to connections that are now yielding novel partnerships, to conversations that are leading to long-term, cross-sector business relationships.

Highlights from Partnering for Cures 2009
 

Partnering for Cures 2009 highlighted best practices in the conduct and management of medical research and outcomes-oriented approaches. This first-of-its-kind conference convened by FasterCures provided participants with a unique opportunity to learn first-hand from cure entrepreneurs - nonprofit leaders who are producing dramatic results for patients.

Meeting highlights:

  • Over 625 medical research executives, scientists, policy makers, and funders from more than 575 organizations explored novel development approaches and innovative funding strategies 
  • 82 speakers, among the most forward‐thinking leaders spotlighted solutions to decades‐long challenges facing the medical research system
  • 42 medical research foundations presented their research portfolio and development strategies 
  • more than 500 one‐on‐one meetings scheduled through the partnering database numerous networking opportunities that facilitated productive collisions between innovators, philanthropists, venture capital investors, decision and policy makers, and patient advocates

Partnering for Cures provided a platform for discussion of some of the most important issues in medical research, including:

  • venture philanthropy’s role in promoting innovative approaches to medical research
  • smarter, more informed philanthropic investments in disease research 
  • patient engagement in clinical research 
  • effective and efficient translation of scientific discoveries into accessible medical solutions
     

We've heard Partnering for Cures characterized as:

"...a game‐changing meeting"

"...an idea‐mosh pit"

"...the most important meeting this year"

"...an effort that captured a movement that's poised to drive change that makes a real difference in people's lives"

 

At FasterCures, we believe the most valuable aspect of this meeting was the coming together of sectors to explore partnerships needed to turn a scientific discovery into a life‐saving therapy.

 

Meeting Highlights
Opening Plenary: Paving the Way to Cross-Sector Collaborations
A Conversation Between Mike Milken and Pfizer CEO Jeffrey Kindler
Breakthrough Science: Plenary with Some of Medical Research's Most Forward-Thinking Leaders
Lunch Plenary - A Conversation between Mike Milken, Gail Cassell, and Joshua Sharfstein
Meeting Coverage:

Maria Bartiromo, anchor of CNBC's Closing Bell, speaks with Dr. Joshua Sharfstein, FDA deputy commissioner; Dr. Gail Cassell, Eli Lilly & Co. vice president for scientific affairs and Michael Milken, FasterCures chairman about preventing chronic disease, investing in innovation, putting a cost on cures, ensuring access, and forecasting the promise of healthcare reform. View interview »

For more information, meeting highlights, videos, and presentations, visit: www.partneringforcures.org